| Year |
Citation |
Score |
| 2020 |
Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, Brooks JD, Dash A, Gleave ME, Martin F, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Carroll PR, et al. Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability. Jama Oncology. e203187. PMID 32852532 DOI: 10.1001/Jamaoncol.2020.3187 |
0.369 |
|
| 2020 |
Chan S, Wang X, Jazić I, Peskoe S, Zheng Y, Cai T. Developing and evaluating risk prediction models with panel current status data. Biometrics. PMID 32562264 DOI: 10.1111/Biom.13317 |
0.333 |
|
| 2020 |
Liss MA, Newcomb LF, Zheng Y, Garcia MP, Filson CP, Boyer H, Brooks JD, Carroll PR, Cooperberg MR, Ellis WJ, Gleave ME, Martin FM, Morgan T, Nelson PS, Wagner AA, et al. Magnetic Resonance Imaging for the Detection of High-Grade Cancer in the Canary Prostate Active Surveillance Study. The Journal of Urology. 101097JU000000000000. PMID 32343189 DOI: 10.1097/Ju.0000000000001088 |
0.332 |
|
| 2020 |
Lin DW, Zheng Y, McKenney JK, Brown MD, Lu R, Crager M, Boyer H, Tretiakova M, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Kolb S, Liss M, Morgan TM, et al. 17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902267. PMID 32130059 DOI: 10.1200/Jco.19.02267 |
0.333 |
|
| 2020 |
Zheng Y, Hua X, Win AK, MacInnis RJ, Gallinger S, Le Marchand L, Lindor NM, Baron JA, Hopper JL, Dowty JG, Antoniou AC, Zheng J, Jenkins MA, Newcomb PA. A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31932410 DOI: 10.1158/1055-9965.Epi-19-0929 |
0.369 |
|
| 2020 |
Waisman Malaret* AJ, Zhu K, Zheng Y, Newcomb L, Chang P, Olugbade KO, Brooks JD, Carroll P, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, et al. PD62-09 EVALUATING THE OUTCOMES OF ACTIVE SURVEILLANCE IN GLEASON GRADE GROUP 2 PROSTATE CANCER The Journal of Urology. 203: e1289. DOI: 10.1097/Ju.0000000000000979.09 |
0.316 |
|
| 2019 |
Wang Y, Zhao YQ, Zheng Y. Learning-based biomarker-assisted rules for optimized clinical benefit under a risk-constraint. Biometrics. PMID 31833561 DOI: 10.1111/Biom.13199 |
0.332 |
|
| 2019 |
Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, et al. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study (PASS). The Journal of Urology. 101097JU000000000000. PMID 31651227 DOI: 10.1097/Ju.0000000000000621 |
0.36 |
|
| 2019 |
Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, et al. Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium. Journal of the National Cancer Institute. PMID 31292633 DOI: 10.1093/Jnci/Djz137 |
0.338 |
|
| 2019 |
Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, Garcia M, Chubak J, Doubeni C, Quinn VP, Haas JS, Li CI, Wernli KJ, Klabunde CN. Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type. American Journal of Preventive Medicine. 56: e143-e152. PMID 31003603 DOI: 10.1016/J.Amepre.2019.01.005 |
0.318 |
|
| 2019 |
Newcomb LF, Zheng Y, Faino AV, Bianchi-Frias D, Cooperberg MR, Brown MD, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Liss M, Morgan TM, Thompson IM, Wagner AA, Carroll PR, et al. Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS). Prostate Cancer and Prostatic Diseases. PMID 30664734 DOI: 10.1038/S41391-018-0124-Z |
0.372 |
|
| 2019 |
Lin DW, Zheng Y, McKenney J, Brown M, Lu R, Crager M, Boyer H, Brooks JD, Dash A, Fabrizio M, Gleave M, Liss MA, Morgan TM, Thompson IM, Wagner A, et al. Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS). Journal of Clinical Oncology. 37: 262-262. DOI: 10.1200/Jco.2019.37.7_Suppl.262 |
0.347 |
|
| 2019 |
Kearns J, Brown M, Faino A, Cooperberg M, Zheng Y, Newcomb L, Lin D, Gore J. Pd50-11 A Risk Calculator Interface And Prediction Model For Upgrading On Active Surveillance For Prostate Cancer: Results From The Canary Prostate Active Surveillance Study The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556886.93327.C1 |
0.347 |
|
| 2019 |
Liss* M, Garcia M, Zheng Y, Newcomb L, Filson C, Boyer H, Brooks J, Carroll P, Gleave M, Martin F, Morgan T, Nelson P, Wagner A, Thompson I, Lin D. PD50-01 ASSESSMENT OF MRI PERFORMANCE IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556876.83918.Db |
0.344 |
|
| 2019 |
Newcomb* L, Zheng Y, Faino A, Schenk J, Brooks J, Cooperberg M, Dash A, Gleave M, Liss M, Martin F, Morgan T, Nelson P, Wagner A, Thompson I, Lin D. MP48-15 EVALUATION OF POTENTIAL BIAS IN RISK FACTOR ASSESSMENT IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556449.83860.B5 |
0.324 |
|
| 2018 |
Liu D, Cai T, Lok A, Zheng Y. Nonparametric Maximum Likelihood Estimators of Time-Dependent Accuracy Measures for Survival Outcome Under Two-Stage Sampling Designs. Journal of the American Statistical Association. 113: 882-892. PMID 30555194 DOI: 10.1080/01621459.2017.1295866 |
0.318 |
|
| 2018 |
Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30459208 DOI: 10.1158/1055-9965.Epi-18-0452 |
0.332 |
|
| 2018 |
Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, et al. Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS). The Journal of Urology. PMID 30076904 DOI: 10.1016/J.Juro.2018.07.065 |
0.343 |
|
| 2018 |
Maziarz M, Cai T, Qi L, Lok AS, Zheng Y. Evaluating longitudinal markers under two-phase study designs. Biostatistics (Oxford, England). PMID 29912281 DOI: 10.1093/Biostatistics/Kxy013 |
0.332 |
|
| 2018 |
Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt SI, Caan B, Campbell PT, Chan AT, Chang-Claude J, Giles GG, Gong J, Harrison TA, Huyghe JR, Jacobs EJ, ... ... Zheng Y, et al. Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology. PMID 29458155 DOI: 10.1053/J.Gastro.2018.02.021 |
0.334 |
|
| 2018 |
Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, ... Zheng Y, et al. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes. European Urology. PMID 29433975 DOI: 10.1016/J.Eururo.2018.01.017 |
0.334 |
|
| 2018 |
Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Lin DW. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. European Urology. PMID 29433973 DOI: 10.1016/J.Eururo.2018.01.016 |
0.351 |
|
| 2018 |
Cooperberg MR, Faino AV, Newcomb LF, Carroll P, Kearns JT, Brooks JD, Fabrizio M, Gleave M, Morgan TM, Dash A, Nelson P, Thompson IM, Wagner A, Lin DW, Zheng Y. When can active surveillance be less active? Prediction of long-term nonreclassification for men with low-risk prostate cancer. Journal of Clinical Oncology. 36: 140-140. DOI: 10.1200/Jco.2018.36.6_Suppl.140 |
0.384 |
|
| 2018 |
Cooperberg M, Faino A, Newcomb L, Carroll P, Kearns J, Brooks J, Fabrizio M, Gleave M, Morgan T, Dash A, Nelson P, Thompson I, Wagner A, Zheng Y, Lin D. PD20-01 WHEN CAN ACTIVE SURVEILLANCE (AS) BE LESS ACTIVE? PREDICTION OF LONG-TERM NON-RECLASSIFICATION FOR MEN WITH LOW-RISK PROSTATE CANCER Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1005 |
0.343 |
|
| 2017 |
Zheng Y, Brown M, Lok A, Cai T. IMPROVING EFFICIENCY IN BIOMARKER INCREMENTAL VALUE EVALUATION UNDER TWO-PHASE DESIGNS. The Annals of Applied Statistics. 11: 638-654. PMID 28943991 DOI: 10.1214/16-Aoas997 |
0.321 |
|
| 2017 |
Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll P, Dash A, Ellis WJ, Fabrizio M, Gleave M, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW. The use of five-alpha reductase inhibitors and their association with reclassification and pathologic outcomes in the Canary Prostate Active Surveillance Study (PASS). Journal of Clinical Oncology. 35: 22-22. DOI: 10.1200/Jco.2017.35.6_Suppl.22 |
0.356 |
|
| 2017 |
Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Zheng Y, Lindor NM, Newcomb PA, Hopper JL, MacInnis RJ. Abstract PR10: Development of a comprehensive colorectal cancer risk prediction tool (CRiPT) incorporating known and unknown major genes and polygenes Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-Pr10 |
0.391 |
|
| 2017 |
Zheng Y, Hua X, Win AK, Jenkins M, Macinnis R, Newcomb P. Abstract PR05: Does a comprehensive family history of colorectal cancer improve risk prediction? Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-Pr05 |
0.4 |
|
| 2017 |
Burnett-Hartman A, Newcomb PA, Zeng CX, Zheng Y, Inadomi JM, Fong C, Upton MP, Grady WM. Abstract PR05: Using medical informatics to evaluate the risk of colorectal cancer in patients with clinically diagnosed sessile serrated polyps Cancer Research. 77. DOI: 10.1158/1538-7445.Crc16-Pr05 |
0.398 |
|
| 2017 |
Cooperberg M, Brooks J, Faino A, Zheng Y, Kearns J, Carroll P, Dash A, Fabrizio M, Gleave M, Morgan T, Nelson P, Thompson I, Wagner A, Newcomb L, Lin D. MP43-11 REFINED ANALYSIS OF PROSTATE SPECIFIC ANTIGEN (PSA) VELOCITY TO PREDICT OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1321 |
0.3 |
|
| 2017 |
Kearns J, Faino A, Newcomb L, Brooks J, Carroll P, Dash A, Ellis W, Fabrizio M, Gleave M, Morgan T, Nelson P, Thompson I, Wagner A, Zheng Y, Lin D. MP43-10 THE ROLE OF SURVEILLANCE BIOPSY WITH NO CANCER AS A PROGNOSTIC MARKER FOR RECLASSIFICATION: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1320 |
0.357 |
|
| 2016 |
Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll PR, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, ... ... Zheng Y, et al. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study. European Urology. PMID 27889277 DOI: 10.1016/J.Eururo.2016.11.017 |
0.351 |
|
| 2016 |
Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Lin DW. Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study. The Journal of Urology. PMID 27810448 DOI: 10.1016/J.Juro.2016.10.090 |
0.349 |
|
| 2016 |
Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, ... ... Zheng Y, et al. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27799157 DOI: 10.1158/1055-9965.Epi-16-0693 |
0.312 |
|
| 2016 |
Leung F, Bernardini MQ, Brown MD, Zheng Y, Molina R, Bast RC, Davis G, Serra S, Diamandis EP, Kulasingam V. Validation of a novel biomarker panel for the detection of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27448593 DOI: 10.1158/1055-9965.Epi-15-1299 |
0.357 |
|
| 2016 |
Maziarz M, Heagerty P, Cai T, Zheng Y. On longitudinal prediction with time-to-event outcome: Comparison of modeling options. Biometrics. PMID 27438160 DOI: 10.1111/Biom.12562 |
0.529 |
|
| 2016 |
Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll PR, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, et al. A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment. Prostate Cancer and Prostatic Diseases. PMID 27431498 DOI: 10.1038/Pcan.2016.28 |
0.372 |
|
| 2016 |
McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, et al. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. American Journal of Preventive Medicine. PMID 27132628 DOI: 10.1016/J.Amepre.2016.03.017 |
0.309 |
|
| 2016 |
Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. American Journal of Preventive Medicine. PMID 27050413 DOI: 10.1016/J.Amepre.2016.02.025 |
0.302 |
|
| 2016 |
Payne R, Yang M, Zheng Y, Jensen MK, Cai T. Robust risk prediction with biomarkers under two-phase stratified cohort design. Biometrics. PMID 27037494 DOI: 10.1111/Biom.12515 |
0.354 |
|
| 2016 |
Konerman MA, Brown M, Zheng Y, Lok AS. Dynamic prediction of risk of liver-related outcomes in chronic hepatitis C using routinely collected data. Journal of Viral Hepatitis. PMID 26893198 DOI: 10.1111/Jvh.12509 |
0.311 |
|
| 2016 |
Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM, et al. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26843520 DOI: 10.1158/1055-9965.Epi-15-0470 |
0.309 |
|
| 2016 |
Lin D, Brown M, Newcomb L, Sjoberg D, Brooks J, Carroll P, Dash A, Fabrizio M, Gleave M, Morgan T, Nelson P, Thompson I, Zheng Y. PD08-02 EVALUATING THE FOUR KALLIKREIN PANEL OF THE 4KSCORE FOR PREDICTION OF HIGH-GRADE PROSTATE CANCER IN MEN IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2818 |
0.33 |
|
| 2015 |
Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, ... ... Zheng Y, et al. Outcomes of active surveillance for the management of clinically localized prostate cancer in the prospective, multi-institutional Canary PASS cohort. The Journal of Urology. PMID 26327354 DOI: 10.1016/J.Juro.2015.08.087 |
0.341 |
|
| 2015 |
Zhou QM, Zheng Y, Chibnik LB, Karlson EW, Cai T. Assessing incremental value of biomarkers with multi-phase nested case-control studies. Biometrics. PMID 26195245 DOI: 10.1111/Biom.12344 |
0.365 |
|
| 2015 |
Cheng TD, Makar KW, Neuhouser ML, Miller JW, Song X, Brown EC, Beresford SA, Zheng Y, Poole EM, Galbraith RL, Duggan DJ, Habermann N, Bailey LB, Maneval DR, Caudill MA, et al. Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study. Cancer. PMID 26108676 DOI: 10.1002/Cncr.29465 |
0.352 |
|
| 2015 |
Zhao S, Zheng Y, Prentice RL, Feng Z. Two-stage biomarker panel study and estimation allowing early termination for futility. Biostatistics (Oxford, England). 16: 799-812. PMID 25964662 DOI: 10.1093/Biostatistics/Kxv017 |
0.368 |
|
| 2015 |
Hsu L, Jeon J, Brenner H, Gruber SB, Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du M, Gong J, Harrison TA, Hayes RB, Hoffmeister M, Hutter CM, Lin Y, ... ... Zheng Y, et al. A model to determine colorectal cancer risk using common genetic susceptibility Loci. Gastroenterology. 148: 1330-1339.e14. PMID 25683114 DOI: 10.1053/J.Gastro.2015.02.010 |
0.353 |
|
| 2015 |
Neuhouser ML, Cheng TY, Beresford SA, Brown E, Song X, Miller JW, Zheng Y, Thomson CA, Shikany JM, Vitolins MZ, Rohan T, Green R, Ulrich CM. Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study. International Journal of Cancer. Journal International Du Cancer. 137: 930-9. PMID 25643945 DOI: 10.1002/Ijc.29453 |
0.355 |
|
| 2015 |
Konerman M, Brown M, Zheng Y, Lok AS. 810 Identifying Patients With Chronic Hepatitis C at High Risk for Clinical Outcomes: Improving Predictive Models of Disease Progression With Novel Methods Integrating Longitudinal Data Gastroenterology. 148: S-998. DOI: 10.1016/S0016-5085(15)33410-7 |
0.305 |
|
| 2015 |
Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Yang H, Lin DW. PD34-03 TIMING OF THE CONFIRMATORY BIOPSY IN PROSTATE CANCER ACTIVE SURVEILLANCE: ANALYSIS OF THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2239 |
0.39 |
|
| 2014 |
Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng TY, Miller JW, Green R, Lane DS, Beresford SA, Caudill MA. Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study. Cancer Research. 74: 7442-52. PMID 25336191 DOI: 10.1158/0008-5472.Can-14-1835 |
0.377 |
|
| 2014 |
Liu D, Zheng Y, Prentice RL, Hsu L. Estimating Risk with Time-to-Event Data: An Application to the Women's Health Initiative. Journal of the American Statistical Association. 109: 514-524. PMID 25018574 DOI: 10.1080/01621459.2014.881739 |
0.36 |
|
| 2014 |
Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA, Halm EA, Gupta S, Wernli KJ, Klabunde C. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1147-58. PMID 24917182 DOI: 10.1158/1055-9965.Epi-13-1217 |
0.327 |
|
| 2014 |
Abbenhardt C, Miller JW, Song X, Brown EC, Cheng TY, Wener MH, Zheng Y, Toriola AT, Neuhouser ML, Beresford SA, Makar KW, Bailey LB, Maneval DR, Green R, Manson JE, et al. Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women. The Journal of Nutrition. 144: 714-21. PMID 24647390 DOI: 10.3945/Jn.113.183970 |
0.305 |
|
| 2014 |
Cheng TY, Goodman GE, Thornquist MD, Barnett MJ, Beresford SA, LaCroix AZ, Zheng Y, Neuhouser ML. Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers. International Journal of Cancer. Journal International Du Cancer. 135: 2135-45. PMID 24622914 DOI: 10.1002/Ijc.28846 |
0.308 |
|
| 2014 |
Hsu L, Jeon J, Brenner H, Berndt S, Chan AT, Chang-Claude J, Gruber SB, Harrison T, Hoffmeister M, Newcomb P, Potter J, Schumacher F, Slattery M, Thomas D, White E, ... Zheng Y, et al. Abstract 2921: Assessing colorectal cancer risk using known genetic susceptibility variants and family history accounting for endoscopy Cancer Research. 74: 2921-2921. DOI: 10.1158/1538-7445.Am2014-2921 |
0.383 |
|
| 2014 |
Cheng TD, Makar KW, Neuhouser ML, Miller JW, Song X, Brown EC, Beresford SAA, Zheng Y, Duggan DJ, Poole EM, Habermann N, Toth R, Bailey LB, Caudill MA, Ulrich CM. Abstract 2197: Interaction between genetic variants in one-carbon metabolism and folate biomarkers on colorectal cancer risk: The Women's Health Initiative observational cohort Cancer Research. 74: 2197-2197. DOI: 10.1158/1538-7445.Am2014-2197 |
0.315 |
|
| 2014 |
Habermann N, Brown E, Toth R, Scherer D, Buck K, Cheng TD, Makar KW, Neuhouser ML, Zheng Y, Duggan DJ, Beresford SA, Wener M, Ochs-Balcom H, Toriola A, Ulrich CM. Abstract 2186: Inflammation- and angiogenesis- related genes: Interaction with NSAID use, and serum inflammatory markers on colorectal cancer risk within the Women's Health Initiative Cancer Research. 74: 2186-2186. DOI: 10.1158/1538-7445.Am2014-2186 |
0.358 |
|
| 2013 |
Cai T, Zheng Y. Resampling Procedures for Making Inference under Nested Case-control Studies. Journal of the American Statistical Association. 108: 1532-1544. PMID 24436503 DOI: 10.1080/01621459.2013.856715 |
0.333 |
|
| 2013 |
Zhou QM, Zheng Y, Cai T. Assessment of biomarkers for risk prediction with nested case-control studies. Clinical Trials (London, England). 10: 677-9. PMID 24013405 DOI: 10.1177/1740774513498321 |
0.373 |
|
| 2013 |
Schenk JM, Hunter-Merrill R, Zheng Y, Etzioni R, Gulati R, Tangen C, Thompson IM, Kristal AR. Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia? American Journal of Epidemiology. 178: 741-51. PMID 23813705 DOI: 10.1093/Aje/Kwt044 |
0.335 |
|
| 2013 |
Zheng Y, Cai T, Pepe MS. Adopting nested case-control quota sampling designs for the evaluation of risk markers. Lifetime Data Analysis. 19: 568-88. PMID 23807695 DOI: 10.1007/S10985-013-9270-8 |
0.336 |
|
| 2013 |
Miller JW, Beresford SA, Neuhouser ML, Cheng TY, Song X, Brown EC, Zheng Y, Rodriguez B, Green R, Ulrich CM. Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. The American Journal of Clinical Nutrition. 97: 827-34. PMID 23426034 DOI: 10.3945/Ajcn.112.049932 |
0.37 |
|
| 2013 |
Zhou QM, Zheng Y, Cai T. Subgroup specific incremental value of new markers for risk prediction. Lifetime Data Analysis. 19: 142-69. PMID 23263882 DOI: 10.1007/S10985-012-9235-3 |
0.369 |
|
| 2013 |
Zschäbitz S, Cheng TY, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Maneval DR, Beresford SA, Lane D, Shikany JM, Ulrich CM. B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. The American Journal of Clinical Nutrition. 97: 332-43. PMID 23255571 DOI: 10.3945/Ajcn.112.034736 |
0.303 |
|
| 2013 |
Zheng Y, Parast L, Cai T, Brown M. Evaluating incremental values from new predictors with net reclassification improvement in survival analysis. Lifetime Data Analysis. 19: 350-70. PMID 23254468 DOI: 10.1007/S10985-012-9239-Z |
0.352 |
|
| 2013 |
Feng Z, Kagan J, Pepe M, Thornquist M, Ann Rinaudo J, Dahlgren J, Krueger K, Zheng Y, Patriotis C, Huang Y, Sorbara L, Thompson I, Srivastava S. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers. Clinical Chemistry. 59: 68-74. PMID 23193062 DOI: 10.1373/Clinchem.2012.185140 |
0.304 |
|
| 2013 |
Takahashi T, Shigematsu H, Shivapurkar N, Reddy J, Zheng Y, Feng Z, Suzuki M, Nomura M, Augustus M, Yin J, Meltzer SJ, Gazdar AF. Erratum: Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers(International Journal of Cancer (2012) 132 (499)) International Journal of Cancer. 132. PMID 23169200 DOI: 10.1002/Ijc.27883 |
0.335 |
|
| 2013 |
Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SA, Gunter MJ, Caudill MA, Ulrich CM. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. International Journal of Cancer. Journal International Du Cancer. 132: 2648-58. PMID 23161620 DOI: 10.1002/Ijc.27942 |
0.407 |
|
| 2013 |
Cheng TD, LaCroix AZ, Beresford SAA, Goodman GE, Thornquist MD, Zheng Y, Chlebowski RT, Ho GYF, Neuhouser ML. Abstract 2572: Vitamin D intake and lung cancer risk in the Women's Health Initiative (WHI). Cancer Research. 73: 2572-2572. DOI: 10.1158/1538-7445.Am2013-2572 |
0.303 |
|
| 2013 |
Kypraios D, Brown MD, Zheng Y, Devetzi M, Bassioukas SP, Katerinis P, Malachias A, Xinopoulos D, Arnogiannaki N, Talieri M. Sa2001 Analysis of the Expression and Clinical Significance of Kallikrein-Related Peptidases 8 and 14 (Klk8 & Klk14) in Colon Cancer Gastroenterology. 144: S-356. DOI: 10.1016/S0016-5085(13)61310-4 |
0.321 |
|
| 2012 |
Liu D, Cai T, Zheng Y. Evaluating the predictive value of biomarkers with stratified case-cohort design. Biometrics. 68: 1219-27. PMID 23173848 DOI: 10.1111/J.1541-0420.2012.01787.X |
0.37 |
|
| 2012 |
Zheng Y, Cai T, Jin Y, Feng Z. Evaluating prognostic accuracy of biomarkers under competing risk. Biometrics. 68: 388-96. PMID 22150576 DOI: 10.1111/J.1541-0420.2011.01671.X |
0.389 |
|
| 2012 |
Cai T, Zheng Y. Evaluating prognostic accuracy of biomarkers in nested case-control studies. Biostatistics (Oxford, England). 13: 89-100. PMID 21856652 DOI: 10.1093/Biostatistics/Kxr021 |
0.327 |
|
| 2012 |
Paskow MJ, Abbenhardt C, Miller JW, Song X, Brown EC, Cheng TD, Wener MH, Zheng Y, Toriola AT, Neuhouser ML, Beresford SAA, Makar K, Bailey LB, Maneval DR, Green R, et al. Abstract 34: Relationships between biomarkers of diet, one-carbon metabolism, and inflammation within the Women's Health Initiative observational study. Cancer Epidemiology Biomarkers & Prevention. 21: 34-34. DOI: 10.1158/1055-9965.Gwas-34 |
0.315 |
|
| 2011 |
Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA. Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women. Genes, Chromosomes & Cancer. 50: 875-86. PMID 21910156 DOI: 10.1002/Gcc.20913 |
0.34 |
|
| 2011 |
Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, Grützmann R, Pilarsky C, Gallinger S, Diamandis EP. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Molecular & Cellular Proteomics : McP. 10: M111.008599. PMID 21653254 DOI: 10.1074/Mcp.M111.008599 |
0.31 |
|
| 2011 |
Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. British Journal of Cancer. 104: 763-8. PMID 21304527 DOI: 10.1038/Sj.Bjc.6606041 |
0.374 |
|
| 2011 |
Cai T, Gerds TA, Zheng Y, Chen J. Robust prediction of t-year survival with data from multiple studies. Biometrics. 67: 436-44. PMID 20670303 DOI: 10.1111/J.1541-0420.2010.01462.X |
0.363 |
|
| 2011 |
Toriola AT, Gunter M, Maneval DR, Beresford SA, Ulrich CM, Cheng DT, Neuhouser ML, Wener M, Zheng Y, Brown EC, Miller JW, Song X, Bailey LB. Abstract PR-05: Biomarkers of inflammation predict colorectal cancer risk among women: Results from the Women's Health Initiative Observational Study (WHI-OS) cohort Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-Pr-05 |
0.392 |
|
| 2011 |
Zschäbitz S, Cheng TD, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Bailey LB, Maneval DR, Beresford SA, Ulrich CM. Abstract 1904: B vitamin intake and incidence of colorectal cancer by tumor site and stage: Results from the Women's Health Initiative cohort Cancer Research. 71: 1904-1904. DOI: 10.1158/1538-7445.Am2011-1904 |
0.342 |
|
| 2010 |
Holmes RS, Zheng Y, Baron JA, Li L, McKeown-Eyssen G, Newcomb PA, Stern MC, Haile RW, Grady WM, Potter JD, Le Marchand L, Campbell PT, Figueiredo JC, Limburg PJ, Jenkins MA, et al. Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2023-34. PMID 20696661 DOI: 10.1158/1055-9965.Epi-09-1097 |
0.346 |
|
| 2010 |
Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Burnett-Hartman A, Wurscher MA, Zheng Y, Mandelson MT. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 20: 305-9. PMID 20580999 DOI: 10.1016/J.Ghir.2010.04.001 |
0.301 |
|
| 2010 |
Zheng Y, Heagerty PJ, Hsu L, Newcomb PA. On combining family-based and population-based case-control data in association studies. Biometrics. 66: 1024-33. PMID 20163402 DOI: 10.1111/J.1541-0420.2010.01393.X |
0.506 |
|
| 2010 |
Kuk C, Gunawardana CG, Soosaipillai A, Kobayashi H, Li L, Zheng Y, Diamandis EP. Nidogen-2: a new serum biomarker for ovarian cancer. Clinical Biochemistry. 43: 355-61. PMID 19883638 DOI: 10.1016/J.Clinbiochem.2009.10.012 |
0.345 |
|
| 2010 |
Zheng Y, Cai T, Stanford JL, Feng Z. Semiparametric models of time-dependent predictive values of prognostic biomarkers. Biometrics. 66: 50-60. PMID 19397579 DOI: 10.1111/J.1541-0420.2009.01246.X |
0.392 |
|
| 2010 |
Coghill AE, Passarelli MN, Makar KW, Zheng Y, Potter JD, Wernli KJ, Hutter CM, Newcomb PA. Abstract B73: Body mass index modifies the association between SMAD7 polymorphism rs4939827 and colorectal cancer risk Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B73 |
0.373 |
|
| 2010 |
Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Newcomb PA. Abstract B71: Prediagnostic use of NSAIDs may modify the effect of a genetic polymorphism of SMAD7 (rs4939827) on colorectal cancer survival in women Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B71 |
0.369 |
|
| 2009 |
Wernli KJ, Wang Y, Zheng Y, Potter JD, Newcomb PA. The relationship between gravidity and parity and colorectal cancer risk. Journal of Women's Health (2002). 18: 995-1001. PMID 19575687 DOI: 10.1089/Jwh.2008.1068 |
0.377 |
|
| 2009 |
Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, et al. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Research. 69: 4112-5. PMID 19435894 DOI: 10.1158/0008-5472.Can-09-0028 |
0.349 |
|
| 2009 |
Talieri M, Li L, Zheng Y, Alexopoulou DK, Soosaipillai A, Scorilas A, Xynopoulos D, Diamandis EP. The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer. British Journal of Cancer. 100: 1659-65. PMID 19367279 DOI: 10.1038/Sj.Bjc.6605033 |
0.364 |
|
| 2009 |
Kulasingam V, Zheng Y, Soosaipillai A, Leon AE, Gion M, Diamandis EP. Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer. International Journal of Cancer. Journal International Du Cancer. 125: 9-14. PMID 19322904 DOI: 10.1002/Ijc.24292 |
0.319 |
|
| 2009 |
Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, et al. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 967-75. PMID 19258475 DOI: 10.1158/1055-9965.Epi-08-0878 |
0.34 |
|
| 2009 |
Hsu L, Starr JR, Zheng Y, Schwartz SM. On combining triads and unrelated subjects data in candidate gene studies: an application to data on testicular cancer. Human Heredity. 67: 88-103. PMID 19077426 DOI: 10.1159/000179557 |
0.317 |
|
| 2008 |
Lin H, Feng Z, Yu Y, Zheng Y, Shivapurkar N, Gazdar AF. Application of Multidimensional Selective Item Response Regression Model for Studying Multiple Gene Methylation in SV40 Oncogenic Pathways. Journal of the American Statistical Association. 103: 201-211. PMID 19830254 DOI: 10.1198/016214507000000428 |
0.322 |
|
| 2008 |
Zheng Y, Cai T, Pepe MS, Levy WC. Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome. Journal of the American Statistical Association. 103: 362-368. PMID 19655041 DOI: 10.1198/016214507000001481 |
0.325 |
|
| 2008 |
Oikonomopoulou K, Li L, Zheng Y, Simon I, Wolfert RL, Valik D, Nekulova M, Simickova M, Frgala T, Diamandis EP. Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. British Journal of Cancer. 99: 1103-13. PMID 18766180 DOI: 10.1038/Sj.Bjc.6604630 |
0.344 |
|
| 2008 |
Pepe MS, Zheng Y, Jin Y, Huang Y, Parikh CR, Levy WC. Evaluating the ROC performance of markers for future events. Lifetime Data Analysis. 14: 86-113. PMID 18064569 DOI: 10.1007/S10985-007-9073-X |
0.335 |
|
| 2008 |
Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y. Integrating the predictiveness of a marker with its performance as a classifier. American Journal of Epidemiology. 167: 362-8. PMID 17982157 DOI: 10.1093/Aje/Kwm305 |
0.393 |
|
| 2007 |
Zheng Y, Katsaros D, Shan SJ, de la Longrais IR, Porpiglia M, Scorilas A, Kim NW, Wolfert RL, Simon I, Li L, Feng Z, Diamandis EP. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6984-92. PMID 18056174 DOI: 10.1158/1078-0432.Ccr-07-1409 |
0.325 |
|
| 2007 |
Zheng Y, Heagerty PJ. Prospective accuracy for longitudinal markers. Biometrics. 63: 332-41. PMID 17688486 DOI: 10.1111/J.1541-0420.2006.00726.X |
0.511 |
|
| 2007 |
Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter JD. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Research. 67: 7534-9. PMID 17671225 DOI: 10.1158/0008-5472.Can-06-4275 |
0.362 |
|
| 2007 |
Andersen MR, Drescher CW, Zheng Y, Bowen DJ, Wilson S, Young A, Mclntosh M, Mahony BS, Lowe KA, Urban N. Changes in cancer worry associated with participation in ovarian cancer screening Psycho-Oncology. 16: 814-820. PMID 17225260 DOI: 10.1002/Pon.1151 |
0.357 |
|
| 2007 |
Shivapurkar N, Stastny V, Suzuki M, Wistuba II, Li L, Zheng Y, Feng Z, Hol B, Prinsen C, Thunnissen FB, Gazdar AF. Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Letters. 247: 56-71. PMID 16644104 DOI: 10.1016/J.Canlet.2006.03.020 |
0.337 |
|
| 2006 |
Zheng Y, Cai T, Feng Z. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers. Biometrics. 62: 279-87. PMID 16542256 DOI: 10.1111/J.1541-0420.2005.00441.X |
0.351 |
|
| 2006 |
Cai T, Pepe MS, Zheng Y, Lumley T, Jenny NS. The sensitivity and specificity of markers for event times. Biostatistics (Oxford, England). 7: 182-97. PMID 16079162 DOI: 10.1093/Biostatistics/Kxi047 |
0.362 |
|
| 2005 |
Zheng Y, Heagerty PJ. Partly conditional survival models for longitudinal data. Biometrics. 61: 379-91. PMID 16011684 DOI: 10.1111/J.1541-0420.2005.00323.X |
0.51 |
|
| 2005 |
Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 61: 92-105. PMID 15737082 DOI: 10.1111/J.0006-341X.2005.030814.X |
0.523 |
|
| 2004 |
Zheng Y, Heagerty PJ. Semiparametric estimation of time-dependent ROC curves for longitudinal marker data. Biostatistics (Oxford, England). 5: 615-32. PMID 15475423 DOI: 10.1093/Biostatistics/Kxh013 |
0.515 |
|
| 2002 |
Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM. Detection of ductal carcinoma in situ in women undergoing screening mammography. Journal of the National Cancer Institute. 94: 1546-54. PMID 12381707 DOI: 10.1093/Jnci/94.20.1546 |
0.323 |
|
| Show low-probability matches. |